Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products
Bryan Newman, Kimberly Witzmann
Topics & Concepts
Risk analysis (engineering)DrugProduct (mathematics)BusinessPopulationEquivalence (formal languages)MedicineScientific evidenceBioequivalenceMarketingPublic economicsPharmacologyEconomicsEnvironmental healthEpistemologyBioavailabilityPhilosophyGeometryMathematicsLinguisticsPharmaceutical studies and practicesInhalation and Respiratory Drug DeliveryPharmaceutical Economics and Policy